Cormorant Asset ManagementInvestor Details

Get alertedif Cormorant Asset Management makes an investment
Cormorant Asset Management
Want to know when Cormorant Asset Management invests in a new company?
Portfolio:
Beam Therapeutics (2019: $135,000,000 raised)
Neurogene (2019: $68,500,000 raised)
Nuvera Medical (2019: $15,000,000 raised)
Erasca (2018: $42,000,000 raised)
Stoke Therapeutics Inc (2018: $90,000,000 raised)
Atreca Inc (2018: $125,000,000 raised)
Phasebio Pharmaceuticals Inc (2018: $34,000,000 raised)
Renovia (2018: $42,300,000 raised)
Tricida Inc (2018: $222,300,000 raised)
Constellation Pharmaceuticals Inc (2018: $100,000,000 raised)
Eidos Therapeutics (2018: $64,000,000 raised)
Bigfoot Biomedical Inc (2018: $55,000,000 raised)
Avrobio (2018: $60,000,000 raised)
Tricida Inc (2017: $57,500,000 raised)
Inflarx Gmbh (2017: $55,000,000 raised)
Autolus Ltd (2017: $80,000,000 raised)
Replimune Group Inc (2017: $55,000,000 raised)
Kezar Life Sciences (2017: $50,000,000 raised)
Tp Therapeutics Inc (2017: $45,000,000 raised)
Axonics Modulation Technologies Inc (2017: $14,500,000 raised)
Dicerna Pharmaceuticals Inc (2017: $70,000,000 raised)
Solid Biosciences (2017: $50,000,000 raised)
Bigfoot Biomedical Inc (2016: $35,500,000 raised)
Iconic Therapeutics (2016: $10,000,000 raised)
G1 Therapeutics (2016: $47,000,000 raised)
Immunexcite Inc (2016: $8,600,000 raised)
Quanterix Corp (2016: $46,000,000 raised)
Twist Bioscience Corp (2016: $61,000,000 raised)
Iconic Therapeutics (2016: $40,000,000 raised)
C4 Therapeutics Inc (2016: $73,000,000 raised)
Scholar Rock (2016: $36,000,000 raised)
Wave Life Sciences (2015: $66,000,000 raised)
Aclaris Therapeutics Inc (2015: $40,000,000 raised)
Proteostasis Therapeutics (2015: $37,000,000 raised)
Syndax Pharmaceuticals Inc (2015: $80,000,000 raised)
Ovid Therapeutics Inc (2015: $75,000,000 raised)
Anaptysbio Inc (2015: $40,000,000 raised)
Kezar Life Sciences (2015: $23,000,000 raised)
Jounce Therapeutics (2015: $56,000,000 raised)
Coinvestors:
Ra Capital Management
Redmile Group
Ecor1 Capital
Foresite Capital
ARCH Venture Partners
Bain Capital Life Sciences
Omega Funds
Orbimed
Aju Ib Investment
Hbm Healthcare Investments
Jennison Associates
Sanofi-genzyme Bioventures
Vivo Capital
Arch Overage Fund
Biomed Ventures
Casdin Capital
Cowen Private Investments
Fidelity Biosciences
Fidelity Management
Fidelity Management And Research Company
Leerink Partners Llc
Longitude Capital
Morningside Venture
Mpm Capital
New Enterprise Associates
Nextech Invest Ltd
Osage University Partners
Perceptive Advisors Llc
Quadrant Capital Advisors
Research Company
Rock Springs Capital
Rock Springs Capital Management
Rtw Investments
Senvest Capital
Sibling Capital Ventures
Tavistock Life Sciences
Venrock Healthcare Capital Partners
Visionnaire Ventures
Wellington Management Company
-aperture Venture Partners
9w Capital Management
Abbott Ventures
Advent Life Sciences
Aisling
Aisling Capital
Alexandria Venture Investments
Altitude Life Science Ventures
Amzak Health Investors
Apple Tree Partners
Arix Bioscience
Arrowpoint Partners
Ascension Ventures
Atlas Venture
Bain Capital Ventures Llc
Brace Pharma Capital
Bridgebio Pharma
Bvf Partners
Capital Partnership
City Hill Ventures
Clarus
Cobro Ventures
Cowen And Company Llc
Cowen Healthcare Investments
Deerfield Management
Delos Capital Fund Lp
Domain Associates
Edmond de Rothschild Investment Partners
Eg Capital Group
Eight Roads Ventures
Elan Science One
Eshelman Ventures
Eventide
F-prime Capital
F-prime Capital Partners
Fidelity Management & Research
Fidelity Management & Research Company
Fletcher Spaght Ventures Of Boston
Franklin Templeton Investments
Frazier Healthcare
Goldman Sachs J.p Morgan Securities Llc
Gv
H.i.g Biohealth Partners
Hatteras Venture Partners
Hatteras Venture Partners-astrazeneca
HealthCare Ventures
Hig Capital
Hillhouse Capital
Illumina
Inova Strategic Investments
Janus Capital Group Inc
Janus Henderson Investors
Jdrf T1d Fund
Johnson & Johnson Innovation-jjdc Inc
Kraft Group
Legend Capital
Lilly Asia Ventures
Lilly Asia Ventures (lav)
Limulus Venture Partner
Limulus Venture Partners
Longwood Capital Partners
Longwood Fund
Lumira Capital Corp
Lundbeckfonden Ventures
Lundbeckfund Ventures
Medimmune Ventures Inc
Merieux Developpement
Morningside
Mossrock Capital Llc
Mountain Group Capital Llc
Mountain Group Partners
Neomed Management
New Leaf Venture Partners Llc
Novartis
Novartis Bioventures
Novartis Venture Fund
Novo A/S
Ns Investment
OrbiMed Advisors
Osf Ventures
Paladin Capital Group
Pappas Ventures
Partners Innovation Fund
Pharmstandard International
Polaris Partners
Qiming Venture Partners
Ra Capital
Roche
Samsara Biocapital
Sirona Capital
Skyline Ventures
Sofinnova Ventures
Sphera Global Healthcare Fund
Srone
Surveyor Capital
Sv Health Investors
Sv Tech Ventures
Syncona
Syno Capital
Tekla Capital Management Llc
The Column Group
The Kraft Group
Third Rock Ventures Llc
Topspin Partners
Trinitas Capital
Tufts University
Venrock Healthcare Partners
Viking Global Investors
Wellington Management Co
Wellington Management Company Llp
Western Technology Investment
Woodford Investment Management
Wuxi Healthcare Ventures
Xeraya Capital
This list displays investors that took part in the same funding round as Cormorant Asset Management since March 2012. They are displayed in decreasing order of coinvesting frequency.
Please note that all data is automatically extracted and errors can occur.
The WhoGotFunded team has not necessarily reviewed the information in this page and has not determined if it is accurate and complete.
Inaccurate Data? Help us improve WhoGotFunded: post a comment!